Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Reid

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Current Osteoporosis Reports|June 18, 2010
Update on the use of zoledronic acid in the management of osteoporosisDavid M Reid
Nature Clinical Practice. Endocrinology & Metabolism|June 21, 2007
Can high bone turnover markers identify osteopenic postmenopausal women at risk of future fracture?David M Reid
Therapeutic Advances in Musculoskeletal Disease|February 4, 2020
Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab?David M Reid
The Journal of the British Menopause Society|April 27, 2004
Bisphosphonates: when and for whom?David M Reid
Therapeutic Advances in Musculoskeletal Disease|August 2, 2012
Professor philip sambrook - obituaryDavid M Reid
Maturitas|August 28, 2009
Prevention of osteoporosis after breast cancerDavid M Reid
Menopause International|June 2, 2007
Bisphosphonate-associated osteonecrosis of the jawNeil Basu, David M Reid
Therapeutic Advances in Musculoskeletal Disease|February 3, 2016
Osteoporosis therapeutics: recent developments at ASBMRGordon Mallarkey, David M Reid
Seminars in Musculoskeletal Radiology|January 24, 2003
Quantitative ultrasound in osteoporosisAlison Stewart, David M Reid
The Practitioner|October 20, 2004
Managing osteoporosisDavid Crosbie, David M Reid
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Current Osteoporosis Reports|June 18, 2010
Update on the use of zoledronic acid in the management of osteoporosisDavid M Reid
Nature Clinical Practice. Endocrinology & Metabolism|June 21, 2007
Can high bone turnover markers identify osteopenic postmenopausal women at risk of future fracture?David M Reid
Therapeutic Advances in Musculoskeletal Disease|February 4, 2020
Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab?David M Reid
The Journal of the British Menopause Society|April 27, 2004
Bisphosphonates: when and for whom?David M Reid
Therapeutic Advances in Musculoskeletal Disease|August 2, 2012
Professor philip sambrook - obituaryDavid M Reid
Maturitas|August 28, 2009
Prevention of osteoporosis after breast cancerDavid M Reid
Menopause International|June 2, 2007
Bisphosphonate-associated osteonecrosis of the jawNeil Basu, David M Reid
Therapeutic Advances in Musculoskeletal Disease|February 3, 2016
Osteoporosis therapeutics: recent developments at ASBMRGordon Mallarkey, David M Reid
Seminars in Musculoskeletal Radiology|January 24, 2003
Quantitative ultrasound in osteoporosisAlison Stewart, David M Reid
The Practitioner|October 20, 2004
Managing osteoporosisDavid Crosbie, David M Reid
Pageof 15